Rejuvenating periorbital skin.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient with darkness or wrinkles around the eyes Having a written consent Being over 18 years old
Exclusion criteria
Exclusion criteria: The patient's lack of consent to participating in the study The use of anticoagulant drugs or the presence of bleeding diseases in the person Using topical anti-wrinkle or anti-darkening medicine at the same time Freshly tanned skin Pregnant and lactating patients People who take drugs with the possibility of photosensitivity (such as retinoids) People with active infectious lesions of the skin, including herpes, dermatophytosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of reduction of darkness and wrinkles of the periorbital skin. Timepoint: At the beginning of the study, one month after the first treatment session, one month after the second treatment session, one month after the third treatment session. Method of measurement: Clinical evaluation (obseravation) of two dermatologists. | — |
Secondary
| Measure | Time frame |
|---|---|
| The satisfaction Score of the patient. Timepoint: One month after the first treatment session, one month after the second treatment session, one month after the third treatment session. Method of measurement: Scoring from 1 to 10. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences